Insight Molecular Diagnostics, Inc. (IMDX)
6.52
-0.16
(-2.40%)
USD |
NASDAQ |
Jan 23, 16:00
6.51
-0.01
(-0.15%)
After-Hours: 20:00
Insight Molecular Diagnostics Research and Development Expense (TTM): 11.07M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| FONAR Corp. | 1.709M |
| XWELL, Inc. | -- |
| ProPhase Labs, Inc. | 0.229M |
| Veracyte, Inc. | 67.49M |
| Exagen, Inc. | 6.153M |